NasdaqCM - Nasdaq Real Time Price USD
OncoCyte Corporation (OCX)
3.4400
+0.0500
+(1.47%)
At close: 4:00:00 PM EDT
3.4400
0.00
(0.00%)
After hours: 5:23:20 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-20,713
-20,713
-23,325
-45,568
-35,941
Investing Cash Flow
-512
-512
-932
-4,340
-13,961
Financing Cash Flow
20,429
20,429
12,186
35,806
78,364
End Cash Position
10,336
10,336
11,132
23,203
37,305
Interest Paid Supplemental Data
42
42
7
24
114
Capital Expenditure
-516
-516
-281
-4,340
-2,247
Issuance of Capital Stock
27,814
27,814
13,848
37,718
77,987
Repayment of Debt
-201
-201
-117
-1,429
-1,534
Repurchase of Capital Stock
-5,389
-5,389
-1,118
--
-239
Free Cash Flow
-21,229
-21,229
-23,606
-49,908
-38,188
12/31/2021 - 12/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDSX Biodesix, Inc.
0.5390
-5.64%
XCY.BE OPKO Health Inc
1.2652
+0.06%
SZLSF StageZero Life Sciences Ltd.
0.0030
0.00%
NEO NeoGenomics, Inc.
10.27
+1.78%
PSNL Personalis, Inc.
3.8400
+0.26%
CSTL Castle Biosciences, Inc.
20.63
-1.43%
GH Guardant Health, Inc.
48.30
+1.88%
LH Labcorp Holdings Inc.
228.31
-0.12%
STIM Neuronetics, Inc.
4.4800
+5.66%
PRPO Precipio, Inc.
6.03
-10.40%